Elite Pharmaceuticals Inc (ELTP) stock
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –
Elite Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2016 it was $342.94K, up 29.3% from the year before. The highest annual figure on record is $342.94K in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Mar 31, 2016 | $342.94K | +29.3% |
| FY2015 | Mar 31, 2015 | $265.17K | +149.1% |
| FY2014 | Mar 31, 2014 | $106.44K | – |
| FY2013 | Mar 31, 2013 | $0 | – |
| FY2012 | Mar 31, 2012 | $0 | -100.0% |
| FY2011 | Mar 31, 2011 | $75.46K | – |
See a number that looks wrong?